COPLAND ROAD CAPITAL NEW - Asset Resilience Ratio
COPLAND ROAD CAPITAL NEW (A2P) has an Asset Resilience Ratio of 0.00% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See COPLAND ROAD CAPITAL NEW (A2P) flexibility index to measure the company's free cash flow as a share of total liabilities.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2022–2025)
This chart shows how COPLAND ROAD CAPITAL NEW's Asset Resilience Ratio has changed over time. See COPLAND ROAD CAPITAL NEW net asset quality index to measure how much of total assets are equity-financed.
Liquid Assets Composition Over Time
This chart breaks down COPLAND ROAD CAPITAL NEW's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see COPLAND ROAD CAPITAL NEW stock valuation.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 0% |
| Short-term Investments | €1.31K | 0.0% |
| Total Liquid Assets | €1.31K | 0.00% |
Asset Resilience Insights
- Limited Liquidity: COPLAND ROAD CAPITAL NEW maintains only 0.00% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
COPLAND ROAD CAPITAL NEW Industry Peers by Asset Resilience Ratio
Compare COPLAND ROAD CAPITAL NEW's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Medacta Group SA
SW:MOVE |
Medical Devices | 0.86% |
|
Double Medical Technology Inc
SHE:002901 |
Medical Devices | 12.59% |
|
Shenzhen New Industries Biomedical
SHE:300832 |
Medical Devices | 9.95% |
|
Jafron Biomedical Co Ltd
SHE:300529 |
Medical Devices | 39.15% |
|
Sinocare Inc
SHE:300298 |
Medical Devices | 3.53% |
|
Xiangyu Medical Co. Ltd. A
SHG:688626 |
Medical Devices | 1.53% |
|
INKON Life Technology Co Ltd
SHE:300143 |
Medical Devices | 5.73% |
|
HOB Biotech Group Corp Ltd
SHG:688656 |
Medical Devices | 2.62% |
Annual Asset Resilience Ratio for COPLAND ROAD CAPITAL NEW (2022–2025)
The table below shows the annual Asset Resilience Ratio data for COPLAND ROAD CAPITAL NEW.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 0.00% | €1.31K ≈ $1.54K |
€489.11 Million ≈ $571.82 Million |
-0.27pp |
| 2023-12-31 | 0.27% | €802.49K ≈ $938.19K |
€299.92 Million ≈ $350.63 Million |
-0.23pp |
| 2022-12-31 | 0.50% | €1.18 Million ≈ $1.38 Million |
€236.48 Million ≈ $276.47 Million |
-- |
About COPLAND ROAD CAPITAL NEW
Synektik Spólka Akcyjna provides products, services, and IT solutions for surgery, diagnostic imaging, and nuclear medicine applications in Poland. The company sells medical equipment used in diagnostics and therapy, and nuclear medicine. It is also involved in development of IT solutions used in radiology, as well as research, produces, and sells radiopharmaceutical products used in diagnostics … Read more